An allogeneic allograft is regenerative tissue donated from another individual that is applied to diseased or chronically injured tissues in the recipient.
Our allograft tissue is harvested from live healthy umbilical cord tissue that was donated following Cesarean section During normal birth in the hospital setting, this material was traditionally discarded. Modern technology allows us to carefully screen donors, and then process this material to create allogeneic allograft, according to our tissue bank, accredited by The American Association of Tissue Banks, and our FDA registered laboratory.

The FDA, under its regulation CFR 361, allows the use of donated human tissue in medicine, if the tissue is minimally manipulated and for homologous use. Our tissue meets guidelines for FDA exemption under CFR 361, since the umbilical cord is designated as a structural support tissue, and it is minimally manipulated, that is, it is simply concentrated and cryopreserved tissue.

The allograft tissue is specially prepared by our FDA approved and registered laboratories and can then be injected into chronically diseased musculoskeletal tissue including muscles, ligaments, tendons, and joints.

For more information on Musculoskeletal regenerative medicine and the benefits of allogeneic allograft please call our office at 808-936-1156.